Biondo Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-62,211
Closed -$3.99M 93
2018
Q4
$3.99M Sell
62,211
-46,440
-43% -$3.43M 1.2% 27
2018
Q3
$9.72M Buy
108,651
+120
+0.1% +$10.6K 2.31% 12
2018
Q2
$8.62M Sell
108,531
-3,745
-3% -$311K 2.17% 12
2018
Q1
$10M Sell
112,276
-18,426
-14% -$1.77M 2.61% 9
2017
Q4
$13.6M Sell
130,702
-5,225
-4% -$590K 3.45% 6
2017
Q3
$19.8M Buy
135,927
+1,320
+1% +$180K 5.45% 4
2017
Q2
$17.5M Sell
134,607
-7,215
-5% -$884K 5.06% 4
2017
Q1
$14M Sell
141,822
-380
-0.3% -$45.5K 5% 3
2016
Q4
$16.5M Sell
142,202
-840
-0.6% -$93.5K 5.44% 3
2016
Q3
$15M Buy
143,042
+1,105
+0.8% +$120K 5.06% 4
2016
Q2
$14M Sell
141,937
-2,297
-2% -$238K 5% 3
2016
Q1
$14.4M Sell
144,234
-55,735
-28% -$5.74M 5.47% 3
2015
Q4
$23.9M Sell
199,969
-7,795
-4% -$902K 7.94% 1
2015
Q3
$22.5M Sell
207,764
-3,124
-1% -$388K 7.47% 1
2015
Q2
$24.4M Sell
210,888
-1,059
-0.5% -$121K 7.33% 1
2015
Q1
$24.4M Sell
211,947
-3,155
-1% -$377K 7.25% 2
2014
Q4
$24.1M Buy
215,102
+3,615
+2% +$381K 7.24% 2
2014
Q3
$20M Sell
211,487
-4,180
-2% -$377K 6.16% 2
2014
Q2
$18.5M Sell
215,667
-1,381
-0.6% -$105K 5.84% 2
2014
Q1
$15.2M Sell
217,048
-6,928
-3% -$549K 5.02% 5
2013
Q4
$18.9M Sell
223,976
-16,214
-7% -$1.28M 6.46% 2
2013
Q3
$18.5M Sell
240,190
-7,580
-3% -$531K 7.02% 2
2013
Q2
$14.5M Buy
+247,770
New +$14.9M 6.28% 5

Other funds holding CELG

Biondo Investment Advisors's CELG Position: Q1 2019 in Review

Biondo Investment Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 62,211 shares — an estimated $3.99M sold.

Biondo Investment Advisors first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $24.4M in Q1 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Biondo Investment Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Biondo Investment Advisors sold 62,211 Celgene Corp shares in Q1 2019, an estimated $3.99M.
  • Biondo Investment Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Biondo Investment Advisors's Celgene Corp position peaked at $24.4M in Q1 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Biondo Investment Advisors's 13F filing for Q1 2019, filed 8 May 2019.